As of May 18
| -0.26 / -0.30%|
The 17 analysts offering 12-month price forecasts for DexCom Inc have a median target of 85.00, with a high estimate of 100.00 and a low estimate of 55.00. The median estimate represents a -1.90% decrease from the last price of 86.65.
The current consensus among 21 polled investment analysts is to Buy stock in DexCom Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.